Sixteen years of evolution of human respiratory syncytial virus subgroup A in Buenos Aires, Argentina: GA2 the prevalent genotype through the years by Viegas, Mariana et al.
  	

Sixteen years of evolution of human respiratory syncytial virus subgroup A in
Buenos Aires, Argentina: GA2 the prevalent genotype through the years
M. Viegas, S. Goya, A.S. Mistchenko
PII: S1567-1348(16)30168-X
DOI: doi: 10.1016/j.meegid.2016.04.034
Reference: MEEGID 2732
To appear in:
Received date: 17 March 2016
Revised date: 28 April 2016
Accepted date: 30 April 2016
Please cite this article as: Viegas, M., Goya, S., Mistchenko, A.S., Sixteen years of evolu-
tion of human respiratory syncytial virus subgroup A in Buenos Aires, Argentina: GA2
the prevalent genotype through the years, (2016), doi: 10.1016/j.meegid.2016.04.034
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Sixteen years of evolution of human respiratory syncytial virus subgroup A in 
Buenos Aires, Argentina: GA2 the prevalent genotype through the years. 
Viegas, M;a,b# Goya, S;a,b and Mistchenko, A. S.a,c 
aVirology Laboratory, Ricardo Gutiérrez Children`s Hospital; Gallo 1330 2º, 
(1425) Ciudad Autónoma Buenos Aires, Argentina  
bConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 
Argentina;  
cComisión de Investigaciones Científicas de la Provincia de Buenos Aires (CIC), 
Argentina. 
e-mail addresses: goyastephanie@conicet.gov.ar; asmistchenko@hotmail.com  
#Corresponding author:  
Mariana Viegas, viegasmariana@conicet.gov.ar, Gallo 1330 2º, (1425) Ciudad 
Autónoma Buenos Aires, Argentina 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Abstract 
Human respiratory syncytial virus (HRSV) is the main viral cause of acute lower 
respiratory tract infections (LRTI) in children worldwide. In recent years, several 
preclinical trials with vaccine candidates have been reported. It is in this sense 
that molecular epidemiological studies become important. Understanding viral 
dispersion patterns before and after the implementation of a vaccine can 
provide insight into the effectiveness of the control strategies. In this work we 
analyzed the molecular epidemiology of HRSV-A over a period of sixteen years 
(1999-2014) in Buenos Aires. By bioinformatic tools we analyzed 169 
sequences of the G glycoprotein gene from hospitalized pediatric patients with 
LRTI. We found that GA2 was the most prevalent genotype (73.35%). GA5 
genotype co-circulated in our region until 2009 when it was no longer detected, 
except in 2011. The recently globally emerging ON1 lineage with a 72-nt 
duplication increased its frequency to become the only lineage detected in 
Buenos Aires in 2014. By discrete phylogeographic analysis of global ON1 
strains we could determine that Panama could be the location of the MRCA 
dated June 20, 2010; and this lineage could be introduced in Argentina from 
Spain in April, 2011. This analysis also showed temporary and geographical 
clustering of ON1 strains observed as phylogenetic clades with strains 
exclusively associated from a single country, nevertheless among our 44 ON1 
strains from three outbreaks (2012-2014) we could also detect posterior 
reintroductions and circulation from United States, Cuba, South Korea, and 
Spain. The continuous phylogeographic analysis of one sublineage of Argentine 
ON1 strains allowed us to establish that there could be a local clustering of 
some strains even in neighborhoods. This work shows the potential of this type 
of bioinformatic tools in the context of a future vaccine surveillance network to 
trace the spread of new genetic lineages in human populations.  
 
Keywords 
HRSV; genotypes; ON1 genetic lineage; phylogeography; circulation patterns. 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
1. Introduction 
Human respiratory syncytial virus (HRSV) is the main viral cause of acute lower 
respiratory tract infections (LRTI) in children under five years of age, being the 
major cause of pediatric hospital admissions during autumn and winter in 
developing countries. In Argentina, HRSV has contributed yearly to 
approximately 78.8% of all viral LRTI among the cited age group (Carballal et 
al., 2001; Videla et al., 1998; Viegas et al., 2004). 
HRSV is an enveloped virus with a non-segmented negative-strand RNA 
genome. It was classified as a member of the Pneumovirus genus of the 
Paramyxoviridae family ( Collins and Karron, 2013)). HRSV exists as a single 
serotype, but has two antigenic subgroups A and B (Coates et al., 1966). 
Among the proteins of HRSV, the G protein stands out for its high degree of 
both sequence and antigenic diversity among different strains, and it has been 
used to classify the circulating viral strains in different genotypes (Peret et al., 
1998). The diversity resides mainly in the ectodomain, which has only 44% of 
amino acid identity between both HRSV subgroups A and B, compared with 
83% for the transmembrane and cytoplasmic domain. This great diversity is 
located in the two variable regions on both sides of a conserved central domain 
rich in Cys (Collins and Karron, 2013). 
Epidemics are commonly produced by both antigenic subgroups, classified in 
more than one genotype. Thirteen HRSV subgroup A (HRSV-A) genotypes 
have been described from different geographical areas, and they have been 
designated from GA1 to GA7 (Peret et al., 2000, 1998), SAA1 (South Africa  
A1) (Venter et al., 2001) and most recently, NA1-NA4 (Cui et al., 2013; 
Shobugawa et al., 2009) and ON1 with a 72-nt duplication (Eshaghi et al., 
2012). HRSV subgroup B (HRSV-B) genotypes include GB1 to GB4 (Peret et 
al., 1998), SAB1 to SAB3 (Venter et al., 2001), URU1-2 (Blanc et al., 2005) and 
BA1 to BA10 (Buenos Aires) with a 60-nt duplication (Dapat et al., 2010; Trento 
et al., 2006, 2003).  
Abbreviations: BA Buenos Aires, BF Bayes factor; ESS effective sample size; IFA 
immunofluorescence assay; LRTI lower respiratory tract infection; MCCT maximum clade 
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credibility tree; MCMC Markov Chain Monte Carlo; MRCA most recent common ancestor; NPA 
nasopharyngeal aspirates; SE standard error. 
Although several studies have reported that both subgroups have shown an 
alternating dominance among outbreaks, in recent years subgroup A has 
prevailed over subgroup B (Duvvuri et al., 2015; Pretorius et al., 2013). 
Recently, Trento et al. reported a reclassification of HRSV-A genotypes on the 
basis of the p-distance method, and they defined the maximum p-distance 
within the GA1 genotype as a cut-off value which defines genotypes. As a 
consequence, they determined that NA1, NA2, NA4 and ON1 which were 
previously classified as emerging genotypes corresponded to emerging genetic 
lineages within the GA2 genotype (Trento et al., 2015).  
Although numerous new genotypes and genetic lineages of HRSV have been 
reported and some emerged recently and others have stopped circulating in the 
population, during the last years, GA2 was the most frequent genotype among 
the studied HRSV-A strains (Trento et al., 2015). The new genetic lineages 
NA1-NA4 and the strain recently described in Canada, ON1probably descended 
from GA2 (Agoti et al., 2014; Cui et al., 2013; Eshaghi et al., 2012; Trento et al., 
2015). 
The emergence in 2010 of the ON1 strain with such a drastic molecular event 
as a 72-nt duplication and the bioinformatic tools based on the Coalescent 
Theory developed in recent years, can allow to describe the population 
dynamics of this new genetic lineage and may provide insights into parameters, 
such as evolutionary rate, location and time of the most recent common 
ancestor (MRCA) and demographic histories that are difficult to assess using 
traditional surveillance analyses. These tools also allow to describe the 
temporospatial diffusion at local and global levels of the ON1 genetic lineage, 
thus describing the transmission chains of HRSV in a simplest way. Our 
laboratory has been conducting the molecular characterization of HRSV for 
sixteen years, and we have found that GA2 (HRSV-A) was the most frequent 
genotype (Viegas and Mistchenko, 2005), and since 2012 we have detected 
almost entirely ON1 strains within HRSV-A. In this context, the aim of this study 
was to perform phylodynamic and phylogeographic analyses of HRSV-A over a 
period of sixteen years at local and global levels by taking advantage of the 
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emergence of the new genetic lineage ON1 to reconstruct viral dispersion 
patterns in space and time. 
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2. Materials and methods 
2.1 Ethical statements 
The study was reviewed and approved by the Medical Ethics and Research 
Committees of Hospital de Niños “Ricardo Gutiérrez”, Buenos Aires, Argentina 
(IRB N° 10.27). Informed consent was not obtained, as patient information was 
anonymized and de-identified prior to analysis. 
2.2 Clinical samples 
The clinical samples were nasopharyngeal aspirates (NPA) which resulted 
positive for HRSV by an indirect immunofluorescence assay (IFA) with 
monoclonal antibodies (Light Diagnostics, Chemicon Int. Inc., USA) (Gardner 
and McQuilin, 1968).They belonged to pediatric patients (<5 years of age) 
hospitalized with acute LRTI at  Hospital de Niños “Ricardo Gutiérrez”, in 
Buenos Aires, Argentina, during 1999-2014. 
The HRSV analyzed in this study corresponds to subgroup A. The subgroup 
was determined on randomly-selected clinical samples by multiplex nested RT-
PCR previously described by Stockton et al. (Stockton et al., 1998). Samples 
which proved positive for HRSV-A were kept frozen at -70ºC until the molecular 
analysis was performed. 
2.3 RNA extraction, G gene amplification and sequencing 
Nucleic acids were extracted directly from NPA samples with a PureLink viral 
RNA/DNA minikit (Invitrogen Life Technologies, Carlsbad, CA, USA) following 
the manufacturer’s instructions. RNA was reverse-transcribed and the 
ectodomain of G glycoprotein gene amplified using the Qiagen OneStep RT-
PCR kit (Qiagen, GmbH, Hilden, Germany) following the manufacturer’s 
instructions with the primers RSVABG10 5'-CGCAATGATAATCTCAACCTC-3' 
and RSVABF1 5'-CAACTCCATKGTTATTTGCC-3'. The retrotranscription and 
amplification conditions for the ectodomain of G glycoprotein gene were: 50ºC 
for 30 min; 95ºC for 15 min followed by 34 cycles of 94ºC for 60 sec, 59ºC for 
60 sec, 72ºC for 120 sec, and a final extension of 72°C for 7 min. 
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PCR products were electrophoresed in a 1.5% agarose gel stained with 
ethidium bromide and purified with the Zymoclean™ Gel DNA Recovery Kit 
(Applied Biosystems, Foster City, CA, USA). The purified PCR products were 
labelled with the BigDye Terminator v3.1 sequencing kit (Applied Biosystems, 
Foster City, CA, USA) and electrophoresed in an ABI3500 genetic analyzer 
(Applied Biosystems, Foster City, CA, USA). 
The consensus nucleotide sequences were analyzed, assembled and 
generated with the SeqScape Software v2.7 (Applied Biosystems, 
Massachusetts, USA) and aligned with CLUSTAL W v2 software (Thompson et 
al., 1994). Most of the sequences corresponding to the period between 1999 
and 2004 were previously published by our group in 2005 (Viegas and 
Mistchenko, 2005). All new sequences were submitted to GenBank (GenBank 
accession numbers: KU350758-KU350870).The viral strains nomenclature 
indicates the country of isolation (Argentina, ARG), the number of the isolate 
(internal laboratory coded number) and the date of sample collection. All 
reference sequences of known genotype were downloaded from GenBank. 
2.4 Phylogenetic analyses 
For the phylogenetic and evolutionary analyses, the general time reversible plus 
gamma distribution (GTR+G) was the most suitable model for the alignment and 
was selected with jModelTest v0.1.1 software (Darriba et al., 2012). The 
Bayesian inference was performed with MrBayes v.3.2.1 software (Ronquist 
and Huelsenbeck, 2003), whereas PhyML v.3.1 software was used for 
Maximum Likelihood (ML) (Guindon et al., 2010) and MEGA v6 software 
(Tamura et al., 2013) for Distance Methods (Neighbor joining, NJ) . Consensus 
trees were visualized with FigTree v.1.4.0. 
2.5 Molecular characterization  
Estimates of mean genetic distances (the number of base differences per site 
from averaging over all sequence pairs, p-distances) were used to calculate the 
divergence among sequences within and between genotypes and genetic 
lineages by using MEGA v6. Standard error (SE) estimates were obtained by 
the bootstrap method (1000 replicates) (Tamura et al., 2013).  
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2.6 Evolutionary rates, population dynamics and phylogeographic analyses 
Evolutionary rates, time of the MRCA, demographic histories, and discrete and 
continuous phylogeographic analyses were estimated from the sequences 
stamped with date and location (latitude and longitude) using the Bayesian 
approach with the BEAST v1.8.2 package (Drummond et al., 2012). The 
uncorrelated lognormal relaxed clock model and the Bayesian skyline 
demographic model were the most suitable implemented models evaluated with 
Bayes Factor (BF)among all molecular clock and demographic models 
available. The convergence of the Markov Chain Monte Carlo (MCMC) 
implemented in the Bayesian criteria was evaluated in TRACER v.1.5 with an 
effective sample size (ESS) >200; the initial 10% of the run length was 
discarded as burn-in. Furthermore, Tracer v1.5 was used to determine the time 
of the MRCA, evolutionary rates and to plot the demographic histories. The 
latter were used to estimate the changes in the effective population size (Ne.τ). 
These results were also analyzed using Tree-Annotator v1.8.2 to infer a 
maximum clade credibility trees (MCCT). The trees were visualized with 
FigTree v1.4.0. The SPREAD v1.0.6 program (Spatial Phylogenetic 
Reconstruction of Evolutionary Dynamics) (Bielejec et al., 2011) was used to 
summarize the phylogeographic analyses in the diffusion dynamic plots and to 
generate the interactive virtual global animations (KML archives) which were 
played by Google Earth (https://earth.google.com). In addition, SPREAD was 
used to calculate the BF to provide substantial strength to migration events 
between two locations (cut-off value BF>10).  
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3. Results 
This study includes a period of sixteen years with a total of 578 HRSV IFA-
positive samples. A total of 371 samples tested positive for subgroup A 
(64.18%) by multiplex nested RT-PCR. Of these, 169 sequences of the 
ectodomain of G glycoprotein gene (593-665 bp) were obtained in our 
laboratory (Table 1). Twenty-six sequences were identical. Fifty-five sequences 
covering the period 1999-2004 had been previously reported by our group 
(Viegas and Mistchenko, 2005) plus a total of 114 new sequences from 2004 to 
2014. 
In order to genotype all Argentine sequences, phylogenetic analyses were 
performed by Bayesian inference, ML and NJ. All phylogenetic analyses were 
carried out using an alignment consisting of all Argentine sequences plus 59 
sequences of known genotype that had been downloaded from GenBank. All 
the phylogenetic analyses were congruent and gave the same association of 
sequences (only Bayesian analysis is shown in Fig. 1, other phylogenetic 
analyses under request). The phylogenetic analyses showed that Argentine 
strains are associated with two clearly defined and well-supported genetic 
clades which correspond with the previously described GA2 and GA5 
genotypes. From the 169 analyzed Argentine sequences, GA2 was the most 
frequent genotype (124/169) and circulated almost all the studied period, except 
during 2002, when only GA5 strains were found, and during 2005 when no 
HRSV-A sequences were detected in Buenos Aires. Both genotypes co-
circulated between 1999 and 2001, 2003 and 2004, 2006 and 2008 and during 
2011. After 2008, GA2 circulated almost exclusively, except in 2011 when GA5 
was also detected (Table 1). It should be noted that only two sequences from 
2007 and three sequences from 2010 were obtained. Unfortunately, due to a 
technical problem, it was not possible to molecularly characterize more strains 
during these years. 
In order to determine the demographic history of both HRSV-A genotypes in 
Buenos Aires, a population dynamics analysis was performed with the 
Argentine sequences. Fig. 2 shows that both genotypes alternated their 
effective populations during the sixteen consecutive years, with a stationary 
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interval during the first years of analysis (1999-mid 2001). After that, there was 
a marked decrease of GA5 between the end of 2000 and the end of 2001, and 
also accompanied by a slight decrease in the effective population of GA2. After 
2002, there was an exponential growth in the population of GA5 which 
surpassed that of GA2 in 2003. Both genotype populations have remained 
almost constant until the period between 2010 and 2011, when the effective 
population of GA5 totally fell. During such period when GA5 was no longer 
detected among the HRSV studied population, a new genetic lineage ON1 had 
emerged globally. 
In the phylogenetic tree of Fig. 1, within GA2 genotype, Argentine sequences 
are distributed throughout the entire clade, associated with sequences reported 
from several parts of the world, except for those belonging to the genetic 
lineages NA3 and NA4. The reference-sequences previously assigned to 
genetic lineages NA1and NA2 do not represent monophyletic clusters in the 
tree, thus the Argentine sequences could not be associated with these lineages. 
A different scenario is observed with the Argentine sequences with 72-nt 
duplication which are associated with reference sequences from ON1 strains in 
a well-defined genetic clade in the tree. In order to determine if this clade 
corresponds to a new genotype, the genetic distances (p-distances) between 
and within genetic clades were calculated for GA2 and ON1. The genetic 
distance was 0.016 (SE 0.002) within ON1, 0.0035 (SE 0.003) within GA2, and 
0.040 (SE 0.005) between GA2 and ON1. Considering that 0.049 was defined 
by Trento et al. as the cut-off value to determine a genotype, ON1 constituted a 
new genetic lineage within GA2 genotype instead of a new genotype (Trento et 
al., 2015). Nevertheless, the frequency of this genetic lineage increased from 
42% (8/19) in 2012, 94.4% in 2013 (17/18) to 100% (19/19) of all HRSV-A 
detected in our laboratory in 2014.  
In order to infer the probable location and the time of the MRCA of ON1 strains 
and how they have been spread throughout the world from its origin, 
phylodynamic and phylogeographic analyses were performed.  
The phylodynamic analysis of 177 ON1 sequences of 665-nt from Argentina 
plus those downloaded from GenBank until June 01,2015, showed that the time 
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of the MRCA for Argentine strains was April 22, 2011 (95% HPD interval; 
January 02, 2011, August 02, 2011) one year before the first ON1 strain was 
detected in our laboratory (April 10, 2012). At the global level the time of the 
MRCA for ON1 strains was June 20, 2010 (95% HPD interval; January 28, 
2010, October 16, 2010), the first ON1 strain analyzed in this study dated from 
October 14, 2010 and was reported in Panama (GenBank accession number 
KF300973.1).The estimated mean evolutionary rate of ON1 strains was 4.87E-
03 subs/site/yr (95% HPD interval: 3.89E03-5.81E-03). 
The discrete phylogeographic analysis depicted by the MCCT (Fig. 3) and 
summarized in the diffusion dynamic plot (Fig. 4), shows that Panama could be 
the location of the MRCA with a probability value of 0.95. It also reveals how the 
different ON1 strains were globally disseminated from Panama. The interactive 
animation (Supplementary KML1) also shows how ON1 strains spread from 
Panama to Canada (BF=54), Spain (BF=29.9), Thailand (BF=18) and China. 
Then, one lineage from Spain disseminated to Argentina (BF=2206.5), and from 
Argentina to Cuba (BF=64.8) and USA (BF=104). It is interesting to note that 
after the first introduction to our country, there were multiple independent 
entries from USA, Cuba, South Korea, and Spain. Another interesting 
observation is how Argentine strains spread to Paraguay and strains from Spain 
entered this neighboring country simultaneously. Nevertheless, if sequences 
published during the preparation of this work from different parts of the world 
had been added to this analysis, it might have been different, however the high 
probability values and BF for each country supports the described dispersions. 
Taking into account the multiple introductions observed in the discrete analysis, 
we really wondered if all ON1 strains have a common ancestor, thus, two 
phylogenetic analyses were performed with an alignment consisted of all 
Argentine sequences from GA2 genotype with and without the duplication. 
Supplementary Fig. 1 shows that the two analyses gave the same association 
of sequences, and all ON1 sequences remained associated on the same cluster 
regardless of not having duplication, supporting the idea that these viruses 
could be generated in a single genetic event. 
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In addition, evaluating the circles around each analyzed country in Fig.4, it is 
possible to see that there are many sampled lineages in our country, supporting 
the idea of multiple reintroductions (determined by the diameter of the circles 
and the color scale). However, it can also be explained by the diversity 
generated in our country. Despite the rapid global distribution of the ON1 
strains, some of these have been circulating only in our region. In the MCCT 
there is a well-supported clade of Argentine strains sampled from 2012 to 2014, 
which displays only local circulation (Fig. 3). In order to analyze the spreading of 
the ON1 strains associated in this Argentine clade exclusively, we performed a 
continuous phylogeographic analysis. The diffusion dynamic plot is shown in 
Fig. 5A (Supplementary KML2). In this figure, it can be seen how these strains 
would have been dispersed in a circumscribed geographical region northwest of 
Buenos Aires . Somehow all these strains would have a geographical 
connection, while the other ON1 Argentine strains without distinction of 
association in the MCCT are distributed homogenously in Buenos Aires (Fig. 
5B). Both the discrete and the continuous phylogeographic analyses can 
explain the circulation of HRSV ON1 strains at the global and local levels.  
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4. Discussion 
Since its discovery in 1955, the HRSV has been the leading cause of acute 
LRTI in children younger than five years of age and older adults, representing a 
public health problem in every studied country. Despite this, there is still no 
approved vaccine for prevention. However, in recent years, several preclinical 
trials have been reported and most are coming to an end, thus the possibility of 
preventing this viral infection seems promising (Karron et al., 2015, 2013). It is 
in this sense that epidemiological studies become important before and after the 
approval of a vaccine. Understanding the phylodynamic shapes of a virus 
spreading before and after the implementation of a vaccine would help to 
quantify the change of the evolutionary rate over time and therefore provide 
insight into the effectiveness of control strategies (Volz et al., 2013).  
In the Virology Laboratory of Hospital de Niños “Ricardo Gutiérrez”, in Buenos 
Aires we have been conducting an active surveillance of acute LRTI in children 
less than five years of age since 1999 (Maffey et al., 2010; Viegas et al., 2004; 
Viegas and Mistchenko, 2005). In this scenario we analyzed the molecular 
epidemiology of HRSV-A over a period of sixteen years (1999-2014).  We found 
that HRSV-A has prevailed over the subgroup B during the study, as it was 
reported in many studies (Pretorius et al., 2013; Shobugawa et al., 2009; Trento 
et al., 2015).  
Despite the long period of time analyzed, we found only two genotypes among 
all HRSV-A virus detected between 1999 and 2014, GA2 and GA5. It is 
important to mention that a lack of detection of any given HRSV genotype does 
not mean that the lineage may have been extinct, since it may be experiencing 
circulation in a different population, such as older people, or it may be still 
circulating in other areas where we did not obtain samples. Thus, we are 
currently conducting a molecular epidemiology analysis of HRSV expanded into 
other areas of our region. Nevertheless, during the last years, many 
researchers have reported that these two genotypes of HRSV-A are almost the 
currently circulating genotypes in many parts of the world (Pretorius et al., 2013; 
Trento et al., 2015). Even more, in bordering countries, such as Brazil, Katzov-
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Eckert et al. reported that these two genotypes were the main responsible for 
HRSV-A outbreaks between 1996 and 2006 (Katzov-Eckert et al., 2012). 
Regarding demographic history of both HRSV-A genotypes of Fig. 2, it is 
interesting to note that the stationary interval of effective populations during the 
first years of the analysis coincides with the globally emergence of BA genotype 
of HRSV-B  (Trento et al., 2010, 2003). It is possible that the emergence of this 
new genotype with a drastic genetic event such as a 60-nt duplication could 
affect the diversity of HRSV-A genotypes. Then the marked decrease of GA5 
between the end of 2000 and the end of 2001 coincides with the appearance 
and fast dissemination of new BA lineages as was described by Trento et al. 
(2010). After this, the exponential growth of GA5 occurred in a period in which 
they reported that the effective population of BA genotype showed a 
depression. In addition, during 2002 GA5 was the only genotype detected 
among all the HRSV-A analyzed strains in our laboratory. After 2004, the 
effective population of both genotypes (GA2 and GA5) remained stationary and 
this was coincident with an exponential growth of BA genotype worldwide due to 
the replacement of all circulating BA lineages by the BA-IV lineage (Trento et 
al., 2010).As it was described by Trento et al. (2015), two events of 
diversification have occurred throughout the history of HRSV-A: one that gave 
rise to GA1, which apparently would be extinct today, and the other that gave 
origin to the currently circulating genotypes (GA2-GA7). While the force that 
gives rise to the phylogenetic tree branching is not entirely known, it is clear that 
we need to unify criteria for designation of genotypes and genetic lineages or 
variants. In the context of a nearby vaccine, global molecular surveillance of 
HRSV should be unified in order to compare data. Some studies, such as those 
of Venter in 2001 (Venter et al., 2001) and Trento in 2015, defined the 
assignment of new genotypes on the basis of genetic distances (p-distances). 
Thus, in their last work, Trento et al. determined a cut-off value of genetic 
distance to define genotype, as the highest intragenotypic p-distance within 
GA1, the oldest genotype far described. This value was obtained analyzing 
2,167 sequences downloaded from GenBank resulting in a value of 0.049. 
Therefore, all the previously defined genotypes NA1-NA4 and ON1 
corresponded to genetic lineages within the GA2 genotype (Trento et al., 2015). 
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Most of the analyzed sequences of HRSV-A in this work were associated with 
GA2 genotype (73.37%). Within this genotype, 44 sequences presented a 72-nt 
duplication in their terminal third and were associated with the previously 
defined ON1 lineage in a well-defined, well-supported genetic clade. It was 
speculated that large epidemics occurred due to the emergence of new genetic 
lineages, as it was observed with NA1 and NA2 in Japan between 2005 and 
2007 (Shobugawa et al., 2009). Since the first detection of ON1 strains in our 
laboratory in 2012, ON1 frequency has been increasing to be the only genetic 
lineage detected within genotype GA2 of HRSV-A in 2014. This result is in 
contrast with the report of Duvvuri et al., where a low prevalence of 13% was 
found in 2011-2012 in Canada, however they explained that it could be due to 
the lack of active surveillance in that country (Duvvuri et al., 2015). In addition, 
the increase in global HRSV surveillance has demonstrated that ON1 lineage is 
disseminating very fast and diversifying in different sublineages as reported in 
Kilifi, Kenya, where two waves of ON1 strains were detected in 2012 with a 
prevalence of 74% (Agoti et al., 2014), as well as an increasing prevalence 
ranging from 60% in 2011-2012 to 89% in 2012-2013, in Texas, USA 
(Avadhanula et al., 2015) and 94.6% in Korea in 2012-2013  (Kim et al., 2014). 
The ON1 genetic lineage, like the BA genotype for HRSV-B, has spread all over 
the world in a very short period of time and it has almost completely replaced 
the other genotypes of HRSV-A, as shown in the phylodynamic analysis of Fig. 
2, where the effective population of GA5 totally fell between 2010 and 
2011concomitant with the emergence of ON1lineage within GA2 genotype 
(Trento et al., 2010). To date we do not know if this drastic duplication provides 
some advantage over related viruses lacking this duplication. However, it is 
interesting that this advantage has not modified the occurrence of the subgroup 
B during the last outbreaks (Table 1). Although subgroup A has prevailed over 
subgroup B during the last three years of this study, a higher percentage of 
subgroup B was detected in 2015 in our laboratory (63.3%) despite this, all 
strains of HRSV-A were ON1 (study currently conducted, data not shown). The 
mechanism by which the 72-nt duplication provides a selective advantage to 
ON1 strains is unknown; but recently Hotard et al. suggested a mechanism 
explaining how BA strains became predominant after their emergence, and a 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
comparable hypothesis could be applied to ON1 strains. They showed that the 
60-nt duplication in a recombinant HRSV strain with a consensus G protein from 
BA genotypes provides advantages in attachment and in a in vitro competitive 
infection assay, rather than the escape from antibody neutralization. They 
hypothesized that the duplication in BA strains which harbor 10 potential O-
glycosylation sites is responsible for the enhanced binding and could lead to 
greater transmission of HRSV in humans. Thereby, the 72-nt duplication of ON1 
strains encodes 11 additional potential glycosylation sites to the existing in the 
previously circulating strains without the duplication (Hotard et al., 2015).  
The discrete phylogeographic analysis with an alignment of ON1 strains (177 
sequences of 665-nt) allowed us to infer that the time of the MRCA for 
Argentine strains dated one year before we detected the first ON1 strain, it is 
important to note that this analysis is restricted to Buenos Aires city and it is 
possible that ON1 strains might be previously circulating in other non-sampled 
locations in Argentina. This analysis also allowed us to infer with a high 
probability that Panama could be the location of the MRCA, dated June, 2010 
with a very narrow HPD interval (January, 2010 to October, 2010). Taking into 
account that the first ON1 strain reported in GenBank is from Panama and 
dated October 14, 2010, it is possible that this place could be the real location 
of the ancestor or a location very close to this country. Duvvuri et al. in 2015 
compared the time of the MRCA among their analyses with multiple set of 
sequences with different lengths and other reports and they found that the 
estimated time of the MRCA ranged from 2007 to 2010, with a median date of 
2008 (Agoti et al., 2014; Duvvuri et al., 2015), we detected a more accurately 
date as seen by the narrow HPD range. It is possible that the longer the 
sequences used in the alignment, the greater the accuracy obtained. In this 
sense, Agoti et al. have demonstrated that the analysis of whole genome 
sequences provided more precise estimates of times of the MRCA and rates of 
nucleotide substitutions (Agoti et al., 2015). Further analyses with whole 
genomes of ON1 strains will help to confirm this observation.  
The discrete phylogeographic analysis also showed temporary and 
geographical clustering of ON1 strains observed as phylogenetic clades with 
strains exclusively associated from a single country (Fig. 3); however the 
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studies reported to date analyzed one or two outbreaks, which could narrow the 
interpretation. Because among our 44 ON1 strains from three outbreaks (2012-
2014) there was geographical clustering since the first introduction from Spain, 
but also posterior reintroductions from USA, Cuba, South Korea, and Spain. As 
more strains will be reported, more interconnections will be observed in the 
future, as it has been found for the other HRSV-A genotypes in previous studies 
(Katzov-Eckert et al., 2012; Pretorius et al., 2013). In addition, we found that 
some GA5 Argentine strains from 2002 to 2004 were closely related to one 
American strain from 2006, and Brazilian strains from 2005 and 2007 were 
closely related with Argentine strains from 2006 to 2008. For GA2 genotype 
(non-lineage ON1), we found a phylogenetic clade with sequences from 
Paraguay, Canada, Saudi Arabia and Argentina, very distant countries, but 
during the same period of time (2009-2011) (Fig. 1). 
In our region, the persistence of one sublineage of ON1 strains allowed us to 
perform a continuous phylogeographic analysis and to establish that there could 
be a local clustering of some strains even in neighborhoods. This study shows 
the potential of this type of bioinformatic tools to trace the spread of a new 
genetic lineage in human populations and to determine precisely in what 
locations will emerge (Holmes, 2008). It is in this sense that we should take 
advantage of this type of genetic events to increase the understanding of the 
evolutionary patterns of HRSV not only for historical significance, but also in the 
context of a future vaccine surveillance network. 
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Table 1. 
Number of HRSV positive samples according to its genotypic characteristics per 
year 
Year 
No. of 
HRSV 
samples* 
No. of 
HRSV-B 
samples (%) 
No. of HRSV-
A samples 
(%) 
No. of HRSV-A  
G sequences 
HRSV-A Genotype 
GA2 GA5 
1999 56 35 (62.50) 21 (37.50) 11 7 4 
2000 44 0 (0) 44 (100) 10 3 7 
2001 41 7 (17.07) 34 (82.93) 11 5 6 
2002 63 45 (71.43) 18 (28.57) 10 0 10 
2003 92 24 (26.09) 68 (73.91) 9 7 2 
2004 57 10 (17.54) 47 (82.46) 15 8 7 
2005 31 31 (100) 0 (0) 0 0 0 
2006 13 3 (23.08)  10 (76.92) 6 5 1 
2007 10 6 (60) 4 (40) 2 1 1 
2008 22 6 (27.27) 16 (72.73) 11 9 2 
2009 12 0 (0) 12 (100) 8 8 0 
2010 12 6 (50) 6 (50) 3 3 0 
2011 28 11 (39.28) 17 (60.72) 17 12 5 
2012 30 0 (0) 30 (100) 19 19 0 
2013 35 10 (28.57) 25 (71.43) 18 18 0 
2014 32 13 (40.62) 19 (59.38) 19 19 0 
Total 578 207 371 169 124 45 
* Number of HRSV IFA-positive samples grouped by multiplex RT-PCR 
(Stockton et al., 1998). The relative percentage of HRSV-A and HRSV-B 
respect to the total of the positive samples is shown in brackets. 
Abbreviation: No., Number. 
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Fig. 1. Bayesian phylogenetic tree. The evolutionary model GTR+G was used 
for Bayesian reconstruction. Bayesian Markov Chain Monte Carlo (MCMC) 
chains were run for 10 million ngen, 10,000 samplefreq to reach convergence 
(split value<0.01; ESS>200) and 10% burnin. The pool sequences include 114 
new sequences from Buenos Aires, 45 sequences from Buenos Aires 
previously reported (Viegas and Mistchenko, 2005) and 59 sequences of known 
genotype from other countries downloaded from GenBank. Node labels 
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represent posterior probabilities (only values above 0.7 are shown). The scale 
bar represents nucleotide substitutions per site. Genotypes GA1-7 and the ON1 
lineage are denoted with vertical lines. Sequences from Buenos Aires are 
remarked with a black circle. 
 
 
Fig. 2. Bayesian skyline plot of HRSV-A genotypes circulating in Buenos Aires. 
Population dynamics of genetic diversity in the genotypes GA2 and GA5, and 
the recent GA2 genetic lineage ON1. The horizontal axis represent time in 
years, the vertical axis represent the population sizes (Ne.Ƭ ). The line with 
diamonds represents GA2, the line with crosses represents GA5 and the 
smooth line represents ON1. The shaded areas show the 95% highest 
probability density interval of these estimates. 
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Fig. 3. Maximum Clade Credibility Tree (MCCT) from the discrete 
phylogeography analysis of ON1 sequences. The branches are in color by 
location of viral samples. The acronym above the branch indicates the country 
of origin for the common ancestor for each clade, and the node labels indicate 
the probability support for this inference. The scale axis is represented inyear. A 
local sublineage is highlighted in grey. 
Acronyms: ARG Argentina, CAN Canada, CB Cuba, CH China, IND India, JP 
Japan, KEN Kenya, PAN Panama, PER Peru, PHI Philippines, PY Paraguay, 
SK South Korea, SPA Spain, THA Thailand ,USA United States. 
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Fig. 4. Diffusion dynamic plot of the discrete phylogeographic analysis of HRSV-
A ON1 genetic lineage. The lines represent the significant connections by 
Bayes Factor (BF) over than 10. White line corresponds to maximum BF and 
black line corresponds to minimum BF. Dates in each location correspond to the 
year of isolation of analyzed strains. The KML file for visualization in Google 
Earth is available as a supplementary file (KML file 1). 
 
 
Fig. 5A. Diffusion dynamic plot of the continuous phylogeographic analysis of 
sequences from local ON1 sublineage (highlighted in MCCT in Fig.3). The KML 
file for visualization in Google Earth is available as a supplementary file 2 (KML 
file 2) 
Fig. 5B. Location of the ON1 Argentine strains without distinction of association 
in the MCCT and showed in Fig.5A. The map is based on satellite images made 
available in Google Earth (http://earth.google.com). 
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Highlights 
 HRSV-A was the most prevalent subgroup during 1999-2014 in BA, 
Argentina. 
 GA2 was the most prevalent genotype and co-circulated with GA5. 
 First ON1 strain emerged in BA in 2012, its frequency increased to 100% in 
2014. 
 Panama could be the location of the MRCA of globally ON1 strains, dated 
June 20, 2010 
 ON1 strains showed temporary and geographical clustering even in 
neighborhoods. 
